Radiopharmaceutical development of a freeze-dried kit formulation for the preparation of [99mTc-EDDA-HYNIC-D-Phe1, Tyr 3]-octreotide, a somatostatin analog for tumor diagnosis

Radiopharmaceutical development of a fre

Radiopharmaceutical development of a freeze-dried kit formulation for the preparation of [99mTc-EDDA-HYNIC-D-Phe1, Tyr3]-octreotide, a somatostatin analog for tumor diagnosis

✍ Elisabeth Von Guggenberg; Renata Mikolajczak; Barbara Janota; Georg Riccabona; C 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

99m Tc-EDDA-HYNIC-D-Phe 1 ,Tyr 3 ]-Octreotide ( 99m Tc-EDDA/HYNIC-TOC) is a promising new radiopharmaceutical with the potential to replace [ 111 In-DTPA-D-Phe 1 ]-Octreotide ( 111 In-DTPA-OCT) as the radiopharmaceutical for somatostatin receptor scintigraphy due to the advantage of improved image